Anti-Mllerian hormone (AMH) is a glycoprotein hormone produced by granulosa cells in ovarian follicles. Its measurement is frequently utilized as an indicator of ovarian reserve, reflecting the quantity of remaining oocytes. Low AMH levels can be a concern for individuals planning conception, particularly those undergoing fertility treatments. Consequently, strategies to elevate AMH are often sought. The goal of this article is to shed light into the potential approach of elevating AMH levels.
Adequate ovarian reserve, indicated by a sufficient AMH level, is vital for successful reproductive outcomes. Individuals with diminished ovarian reserve may experience difficulty conceiving and have a reduced response to ovarian stimulation during assisted reproductive technologies. While AMH declines naturally with age, premature decline can be indicative of underlying reproductive health issues. Research into methods to influence AMH production is ongoing, driven by the potential benefits for fertility management and family planning.